FDA clears additions to Nellcor's Symphony system
This article was originally published in Clinica
Two additions to Nellcor Puritan Bennett's Symphony patient monitoring system have been cleared by the US FDA. They include a three-lead selectable ECG monitoring option for the Symphony N-3000 pulse oximeter, and the N-3200 display/printer for viewing and printing ECG and other parameters.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.